 |
PDBsum entry 3iia
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Mol Cell Proteomics
10:M110.004390
(2011)
|
|
PubMed id:
|
|
|
|
|
| |
|
Cyclic AMP analog blocks kinase activation by stabilizing inactive conformation: conformational selection highlights a new concept in allosteric inhibitor design.
|
|
S.Badireddy,
G.Yunfeng,
M.Ritchie,
P.Akamine,
J.Wu,
C.W.Kim,
S.S.Taylor,
L.Qingsong,
K.Swaminathan,
G.S.Anand.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The regulatory (R) subunit of protein kinase A serves to modulate the activity
of protein kinase A in a cAMP-dependent manner and exists in two distinct and
structurally dissimilar, end point cAMP-bound "B" and C-subunit-bound
"H"-conformations. Here we report mechanistic details of cAMP action
as yet unknown through a unique approach combining x-ray crystallography with
structural proteomics approaches, amide hydrogen/deuterium exchange and ion
mobility mass spectrometry, applied to the study of a stereospecific cAMP
phosphorothioate analog and antagonist((Rp)-cAMPS). X-ray crystallography shows
cAMP-bound R-subunit in the B form but surprisingly the antagonist
Rp-cAMPS-bound R-subunit crystallized in the H conformation, which was
previously assumed to be induced only by C-subunit-binding. Apo R-subunit
crystallized in the B form as well but amide exchange mass spectrometry showed
large differences between apo, agonist and antagonist-bound states of the
R-subunit. Further ion mobility reveals the apo R-subunit as an ensemble of
multiple conformations with collisional cross-sectional areas spanning both the
agonist and antagonist-bound states. Thus contrary to earlier studies that
explained the basis for cAMP action through "induced fit" alone, we
report evidence for conformational selection, where the ligand-free apo form of
the R-subunit exists as an ensemble of both B and H conformations. Although cAMP
preferentially binds the B conformation, Rp-cAMPS interestingly binds the H
conformation. This reveals the unique importance of the equatorial oxygen of the
cyclic phosphate in mediating conformational transitions from H to B forms
highlighting a novel approach for rational structure-based drug design. Ideal
inhibitors such as Rp-cAMPS are those that preferentially "select"
inactive conformations of target proteins by satisfying all "binding"
constraints alone without inducing conformational changes necessary for
activation.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |